banner
home azienda prodotti anatomia contatti
integratori
ombra_sx
red_line
down
icon
More info  
Vitreous floaters or “flying flies” are a progressively diffuse clinical problem.
Ageing, myopia, dietary and digestive changes, unbalanced diets, atmospheric and luminous polluting agents, and eye operations are all factors which contribute to the development of this problem. It is important to target intervention at improving the metabolism and re-establishing the physiological make-up of the structure of the vitreous humour (water, mineral salts, amino acids, and vitamins) in order to minimize this irritating problem.
 
down
down
icon
Download  

Info in Vista
LE MIODESOPSIE

icon_pdf
Download the file (348 Kb)
 
down
down
icon_biblio
Bibliography

1. Sebag J. Age-related changes in human vitreous
structure. Graefe’s Arch Clin Exp Ophthalmol 1987;
225(2):89-93.

2. Ueno N, Sebag J, Hirokawa H, Chakrabarti B. Effects
of visible-light irradiation on vitreous structure in
the presence of a photosensitizer. Exp Eye Res 1987
Jun;44(6):863-870.

3. van Overdam KA, Bettink-Remeijer MW, Mulder
PG, van Meurs JC.
Symptoms predictive for the later
development of retinal breaks. Arch Ophthalmol
2001 Oct;119(10):1483-1486.

4. Kakehashi A, Inoda S, Shimizu Y, Makino S, Shimizu
H.
Predictive value of floaters in the diagnosis of
posterior vitreous detachment. Am J Ophthalmol
1998 Jan;125(1):113-115.

5. Weber Krause B, Eckardt C. Incidence of posterior
vitreous detachment in the elderly. Ophtalmologie
1996 Dec;93(6):660-665.

6. Shepens CL. Fundus changes caused by alteration
of vitreous boby. Am J Ophthal 1995;39;631-633.

7. Plantner JM, et al. Matrix metalloproteinases and
metalloproteinase inhibitors in human interphotoreceptor
matrix and vitreous. Current Eye Research
1998;17:132-140.

8. Sethi C, Bayley T, Luthert P, et al. Matrix metalloproteinase biology applied to vitreoretinal disorders.
Br J Ophthalmol 2000;84:654-666.

9. Alexander J. Growth factor and cytokine modulation
of trabecular meshwork matrix metalloproteinase
and TIMP expression. Curr Eye Res 1998;17:276-285.

10. Plantner J. Membrane type-1 matrix metalloproteinase
in human ocular tissues. Curr Eye Res 1997;
16:925-929.

11. Blumenthal M. Asian ginseng: potential therapeutic
uses Adv Nurse Pract 2001 Feb;9(2):26-28, 33.

12. Miura T, Tatara M, Nakamura K, Suzuki I. Effect of
guarana on exercise in normal and epinephrine-induced
glycogenolytic mice. Biol Pharm Bull 1998 Jun;
21(6):646-648.

13. Espinola EB, Dias RF, Mattei R, Carlini EA. Pharmacological
activity of Guarana (Paullinia cupana Mart.)
in laboratory animals. J Ethnopharmacol 1997 Feb;
55(3):223-229.

14. Pessotto P, Valeri P, Arrigoni-Martelli E. The presence
of L-carnitine in ocular tissues of the rabbit. J
Ocul Pharmacol 1994 Winter;10(4):643-651.

15. Levkovitch-Verbin H, Martin KR, Quigley HA,
Baumrind LA, Pease ME, Valenta D.
Measurement of
amino acid levels in the vitreous humor of rats after
chronic intraocular pressure elevation or optic nerve
transection. J Glaucoma. 2002 Oct;11(5):396-405.

16. Durham DG. Distribution of free amino acids in
human intraocular fluids. Trans Am Ophthalmol Soc
1970;68:462-500.

17. Remer T. Influence of diet on acid-base balance.
Semin Dial 2000 Jul-Aug;13(4):221-226.

18. Ainley RG, Phillips CI, Gibbs A, Acheson RR, Watson-
Williams EJ, Bottomley AC.
Aqueous humour vitamin
B12 and intramuscular cobalamins. Br J
Ophthalmol. 1969 Dec;53(12):854-857.

19. Davidson GE, Weir DG, Scott JM. The metabolic
consequences of vitamin B-12/methionine deficiency
in rats. Biochim Biophys Acta 1975 Jun 12;392(2):
207-215.

 

 
down
 
vitreoxigen
Composition
L-Lysine 200 mg
L-Arginine 125 mg
L-Carnitine 35 mg
Magnesium 150 mg
Potassium 100 mg
Vitamin PP 9 mg
Pantothenic acid 3 mg
Vitamin B 6 1 mg
Vitamin B 2 0,8 mg
Vitamin B 1 0,7 mg
Vitamin B 12 0,5 mcg
Ginseng dry extract 100 mg
Pineapple stem 40 mg
Guaranà dry extract 25 mg
 
Description

Supplement of lysine, magnesium, arginine, potassium, carnitine, and vitamins with vegetable extracts.

In alterations of the vitreous humour

VITREOXIGEN®, thanks to the properties of its ingredients, amino acids (lysine, arginine, carnitine), vegetable extracts (bromelin, ginseng and guaranà), mineral salts (magnesium and potassium), and vitamins (B1, B2, B6, B12, pantothenic acid), helps to improve cellular metabolism and the physiological relationship between the components of the vitreous mass.

 
illustrazione

AMINO ACIDS
Lysine, Arginine, Carnitine: have a direct effect on the production of energy by cells. The correct formation of collagen in the vitreous humour.

MINERALS
Potassium: is an indispensable mineral for the preservation of liquids in the cells since it affects their water-saline balance.
Magnesium: Affects a large variety of enzymes and helps stabilize molecules keeping the connective tissues, which the vitreous humour is part of, in good condition.

VEGETABLE EXTRACTS
Bromelin: helps protect collagen fibres from attack by harmful enzymes (collagenasis and metalloproteinasis).
Ginseng extract: helps the body to adapt to stressful events, of both internal and external origins, thus enabling it to be used as an "adaptogen".
Guaranà extract: strengthens the effect of bromelin.

VITAMINS
B group vitamins: important for all specific metabolic reactions including those for energy production.

 
Product Use

The ingredients in VITREOXIGEN® interact in many metabolic processes in tissues and the vitreous, helping to optimize the intake of energy and replenish the store of amino acids, mineral salts and vitamins when there is an increase in need or reduced dietary intake.

VITREOXIGEN® can be used in the case of increased need for or reduced dietary intake of the nutrients which it contains.

INSTRUCTIONS FOR USE
The recommended dose is 1 or 2 effervescent tablets a day, dissolved in a glass of water (200 ml) in the morning or before noon, before meals.

PACKAGE
Tube containing 20 effervescent tablets.

 

 
 
flaguk end